By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Upsher-Smith Laboratories, Inc. 

14905 23rd Avenue North

Minneapolis  Minnesota  55447  U.S.A.
Phone: 800-328-3344 Fax: n/a


Key Statistics

Ownership: Private

Web Site: Upsher-Smith Laboratories


Company News
Upsher-Smith Laboratories Launches Newly Designed Website For Qudexy XR (topiramate) Extended-Release Capsules 8/21/2017 9:17:57 AM
Saniona's Renames The Upsher-Smith Laboratories Program To Proxima Program 4/28/2017 11:03:06 AM
Upsher-Smith Laboratories’ Generic Biz Gets Taken Out In $1.05 Billion Deal 4/20/2017 7:57:42 AM
Upsher-Smith Laboratories Release: FDA Approves Expanded Indication For Qudexy XR (Topiramate) Extended-Release Capsules To Include Prophylaxis Of Migraine Headache In Adults And Adolescents 3/30/2017 7:44:54 AM
Upsher-Smith Laboratories Announces The Launch Of Generic Clomipramine 3/22/2017 7:25:14 AM
Upsher-Smith Laboratories Enters Agreement To Expand Marketing And Distribution Of Generic Products For U.S. Market 3/17/2017 9:51:15 AM
Upsher-Smith Laboratories Continues To Expand Generic Product Portfolio 11/8/2016 11:41:51 AM
Upsher-Smith Laboratories Presents Data Characterizing The Pharmacokinetics And Safety/Tolerability Of Investigational Midazolam Nasal Spray (Usl261) In Pediatric Participants With Epilepsy 10/28/2016 11:52:29 AM
Upsher-Smith Laboratories Acquires 20 Generic Drug Products 10/18/2016 8:02:29 AM
Upsher-Smith Laboratories Enters Into Exclusive Development And Distribution Agreement With Pharmathen 9/27/2016 7:22:52 AM